Explore our network of esteemed partners who bring
specialized expertise and innovative solutions to our
collaborative efforts in clinical research and drug
development. Together, we deliver comprehensive and
reliable services to our clients, ensuring excellence in
every phase of the process.
A preclinical CRO specializing in animal models for obesity, Type 2 diabetes, and related comorbidities, including NASH, dyslipidemia, inflammation, fibrosis, diabetic nephropathy, neuropathy, HFpEF, and atherosclerosis. With over 20 years of experience, Physiogenex evaluates the efficacy of client drugs using gold-standard and radiotracer-based experiments in validated preclinical models.
Know More
Staburo offers expertise in biostatistics, programming, translational medicine and biomarkers, data transparency, and bioinformatics, providing advanced data science services and programming for international pharmaceutical, CRO, and biotech clients. Partnering with leading pharmaceutical companies, Staburo ensures successful drug development from discovery to patient delivery, providing reliable and flexible support.
Know More
A full-service CRO offering comprehensive clinical development and consulting services across Europe. FGK also offers pharmacovigilance services through its subsidiaries “FGK Pharmacovigilance” and “FGK Representative Services,” including QPPV and PSMF management, as well as legal representation for non-European clients conducting clinical trials or seeking marketing authorization within EU/EEA.
Know More